Publicaties

Dijkstra BAG, Beurmanjer H., Kamal RM, Schellekens A.  2017.  De behandeling van GHB-afhankelijkheid. Medisch Contact.

de Weert-van Oene GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in patients with substance use and co-occurring psychiatric disorders. . Journal of Dual Diagnosis. 13(2)

De Weert GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in Patients With Substance Use and Co-Occurring Psychiatric Disorders.. J Dual Diagn. 13(2):136-143.

Dijkstra BAG, Kamal R, van Noorden MS, de Haan H, Loonen AJM, DeJong CA.  2017.  Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project. Drug Alcohol Depend. 170:164-173.

Luijten M, Schellekens A, Kuhn S, Machielse MW, Sescousse G.  2017.  Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies. Jama Psychiatry. 74(4):387-398.

Martial LC, Aarnoutse RE, Mulder M, Schellekens A, Brüggemann RJM, Burger DM, Schene AH, Batalla A.  2017.  Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.. Eur Neuropsychopharmacol. 27(3):205-216.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  The efficacy of an e-learning prevention program for substance use among adolescents with intellectual disabilities: A pilot study.. Res Dev Disabil. 63:160-166.

Markus W, Hornsveld H.  2017.  EMDR interventions in addiction.. Journal of EMDR Practice and Research. 11(1):27.

Qurishi R., Markus W, Habra M.J.M., Bressers B., DeJong CA.  2017.  EMDR therapy reduces intense treatment-resistant cravings in a case of gamma-Hydroxybutyric acid addiction. Journal of EMDR Practice and Research. 11(1)

Markus W, Geurink M., S. Gi TPian, De Jongh A., Kranenburg L..  2017.   Eye Movement Desensitization and Reprocessing (EMDR) therapie.. Databank(en): Langdurige GGZ..

Dijkstra BAG, van Oort M.  2017.  Handleiding Detoxificatie van psychoactieve middelen. Verantwoord ambulant of intramuraal detoxificeren. Resultaten Scoren.

Verbrugge CAG, Stollenga M..  2017.  Herstelondersteuning in Nederland: een stand van zaken. Naar een herstelondersteunende verslavingszorg. :18.

de Jong MArts-, DeJong CA, Hermens RP, Kissane DW, Massuger LM, Hoogerbrugge N, Prins JB, deHullu JA.  2017.  High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.. J Psychosom Obstet Gynaecol. :1-9.

van Lier H.G., Pieterse M.E., Schraagen J.M.C., Postel M.G., Vollenbroek-Hutten M.M.R., de Haan H.A., Noordzij M.L..  2017.  Identifying viable theoretical frameworks with essential parameters for real-time and real world alcohol craving research: a systematic review of craving models. . Addiction Research & Theory.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  Intellectually disabled and addicted: a call for evidence based tailor-made interventions.. Addiction. 112(11):2067-2068.

van Oosterhout e, DeFuentes-Merillas L, Verbrugge CAG, de Feijter A, Franzek E.  2017.  Langdurig gedwongen ketenzorg onder onafhankelijke regie: een oplossing voor complexe casuistiek. Tijdschrift voor Verslaving. DOI 10.1007/s12501-017-0119-9

Schellekens A, Luijten M, Sescousse G.  2017.  Neuroimaging meta-analyses across psychiatric disorders: challenges and promises. Jama Psychiatry.

Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Lorenzetti V, Yücel M.  2017.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.. Psychopharmacology (Berl).

Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BAG, Schellekens A.  2017.  Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs. 31(1):51-64.

Dijkstra BAG, van Oort M, Schellekens A, De Haan HA, DeJong CA.  2017.  Richtlijn detoxificatie van psychoactieve middelen. Verantwoord ambulant of intramuraal detoxificeren. Resultaten Scoren.

Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S et al..  2017.  Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms.. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):392-400.

Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens A, Loonen AJM.  2017.  The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.

Wits E, Croes E, Dijkstra BAG, van Nattum M.  2017.  Standaarden bieden houvast aan alle zorgverleners. Medisch Contact.

Swerts C, Vandevelde S, VanDerNagel JEl, Vanderplasschen W, Claes C, De Maeyer J.  2017.  Substance use among individuals with intellectual disabilities living independently in Flanders.. Res Dev Disabil. 63:107-117.

VanDerNagel JEl, Kiewik M, van Dijk M, Didden R, Korzilius HPLM, van der Palen J, Buitelaar JK, Uges DRA, Koster RA, DeJong CA.  2017.  Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.. Res Dev Disabil. 63:151-159.